No, THCA remains illegal in Thailand under the Narcotics Act B.E. 2564 (2021), which classifies all tetrahydrocannabinol (THC) derivatives—including THCA—as Category 5 narcotics. The Thai Food and Drug Administration (FDA) enforces this stance, despite recent decriminalization of cannabis for medical use, as THCA is a precursor to THC. Exemptions for research or pharmaceutical applications require prior FDA approval, with stringent oversight.
Key Regulations for THCA in Thailand
- Narcotics Classification: THCA is explicitly listed under the Narcotics Act’s Category 5, criminalizing possession, sale, or distribution without authorization.
- Medical Use Exceptions: Only THC-based pharmaceuticals approved by the FDA (e.g., Epidyolex) are permitted; raw THCA products are prohibited.
- 2026 Compliance Shifts: The FDA is drafting stricter controls on hemp-derived cannabinoids, potentially expanding THCA restrictions to align with international narcotics conventions.
Local enforcement agencies, including the Royal Thai Police and FDA, conduct routine inspections of cannabis-related businesses. Violations may result in imprisonment (up to 5 years) or fines (up to 500,000 THB). Travelers carrying THCA products risk confiscation or legal penalties.